Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

0.9130 USD -0.0499 (-5.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,566,949
Open 0.9600
Bid (Size) 0.9130 (15)
Ask (Size) 0.9200 (7)
Prev. Close 0.9629
Today's Range 0.9000 - 0.9624
52wk Range 0.7500 - 2.940
Shares Outstanding 119,179,806
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
ACRX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities C
From GlobeNewswire News Releases

Performance

YTD
-26.96%
-26.96%
1 Month
-13.87%
-13.87%
3 Month
-24.55%
-24.55%
6 Month
-31.87%
-31.87%
1 Year
-46.61%
-46.61%

More News

Read More
AcelRx Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Rocket, 360 DigiTech, and Piedmont Lithium and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
DEADLINE ALERT for ACRX and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
How Bad Are AcelRx Pharmaceuticals's Earnings? | Return On Capital Employed
Tags Earnings ACRX Benzinga
From Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)
From Business Wire News Releases
12 Health Care Stocks Moving In Wednesday's Intraday Session
Tags MRNS XAIR RGC
From Benzinga
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Long Term Investor Notice: Investigation of Potential Wrongdoing
From SBWire - Latest Press Releases
ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags ME RANI TSHA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]